US Food and Drug Administration (FDA) | The Business Standard
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
FRIDAY, MAY 20, 2022
FRIDAY, MAY 20, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা

US Food and Drug Administration (FDA)

ACI gets first US FDA approval
Stocks

ACI gets first US FDA approval

ACI group continues steady revenue growth with some consolidated profits

A person receives a dose of the Pfizer-BioNTech vaccine for the coronavirus disease (COVID-19), at a mobile inoculation site in the Bronx borough of New York City, New York, U.S., August 18, 2021. REUTERS/David 'Dee' Delgado
World+Biz

U.S. COVID-19 booster debate moves to FDA vaccine advisory committee

Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken, June 24, 2021. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

Full US approval for Pfizer vaccine expected by early September: Report

Pfizer says it will have 15m doses of its vaccine ready for people in the US by the end of the year, if it is approved. Photo: Reuters
Coronavirus chronicle

US FDA set to authorize Pfizer Covid-19 shot for ages 12-15 early next week

Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

US to distribute 4 million J&J Covid vaccines by Tuesday

The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg, France, February 1, 2018. Picture taken February 1, 2018. REUTERS/Vincent Kessler
Coronavirus chronicle

Eli Lilly's antibody combination receives FDA emergency use authorization for Covid-19

Photo: Reuters.
Coronavirus chronicle

9m Americans now vaccinated as US sets Covid-19 death record for second week

US administers first Moderna vaccines
Coronavirus chronicle

US administers first Moderna vaccines

However, the US Food and Drug Administration has said vaccines must demonstrate at least 50% efficacy Representational Photo: BSS/AFP
Coronavirus chronicle

Covid-19 shots could reach first Americans by mid-December

It will be a while before Covid-19 is well-controlled, vaccine or not. In the meantime, testing will be crucial. Photo: Bloomberg
Coronavirus chronicle

FDA approves first Covid-19 test kit for home use

A scientist holds cells that produce antibodies against the coronavirus disease (Covid-19) under a microscope, in a university lab in Athens, Greece, July 8, 2020. Picture taken July 8, 2020/ Reuters
Coronavirus chronicle

US allows emergency use of first Covid-19 antibody drug

Food and Drug Administration (FDA) Commissioner Dr Stephen Hahn addresses the daily coronavirus task force briefing as White House coronavirus coordinator Dr Deborah Birx listens at the White House in Washington, US, April 21, 2020/ Reuters
Coronavirus chronicle

US FDA chief refuses to back Trump's Covid-19 vaccine prediction

Laura Ng, who has lupus and had to recently call at least five pharmacies before she could find a place to fill her hydroxychloroquine prescription, is photographed in Seattle, Washington, US March 31, 2020/ Reuters
Coronavirus chronicle

FDA warns of heart risks with Trump-promoted malaria drug

  • Show More
The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab